跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB EVER PHARMA 2,5 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BORTEZOMIB EVER PHARMA 2,5 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
BORTEZOMIB EVER PHARMA 2,5 MG/ML SOLUCION INYECTABLE
Ever Valinject Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2021
Approval ID
fd32cc7b1e6b6ba6
Company
Ever Valinject Gmbh
Type
Standard
Approval Details
Approval Id
fd32cc7b1e6b6ba6
Drug Cima Aemps Name
BORTEZOMIB EVER PHARMA 2,5 MG/ML SOLUCION INYECTABLE
Register Number
86259
Holder Company Name
Ever Valinject Gmbh
Marketing Company Name
Ever Pharma Therapeutics Spain, S.L.
Authorization Date
2021-12-21
Dosage Form
SOLUCIÓN INYECTABLE
Dose
2.5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Ever Valinject Gmbh
Active Ingredients
BORTEZOMIB
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2021
Approval ID
fd32cc7b1e6b6ba6
Type
Standard
Back to CIMA-AEMPS Approvals
